Study Finds Misleading Online Advertising of Off-Label Ketamine Treatments Despite Lack of FDA Approval and Research Evidence

Misleading Claims Pose Risks to Vulnerable Mental Health Patients Seeking Quick Fixes; Study Raises Concerns Over Growing Popularity and Lack of Regulation of Off-Label Ketamine Treatments Across Hundreds of Clinics Nationwide.